Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MindBio Therapeutics Corp. C.MBIO

MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.


CSE:MBIO - Post by User

Post by Goodtoreadthis1on May 24, 2023 1:18am
203 Views
Post# 35461309

Beautiful baseline

Beautiful baselineMBIO has done solid work building a foundation around their testing and advancement plans for microdosing of LSD. Since the healthy subjects reported positive results, the results to be reported by those with actual depression problems should be as good as the healthy subjects or even better. 

The need for a successful psychedelic treatment could not be greater. 300 million potential users makes this an approach with an enormous economic upside.  
<< Previous
Bullboard Posts
Next >>